Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (unaudited)

v3.10.0.1
Selected Quarterly Financial Data (unaudited)
12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Financial Data (unaudited)

15. Selected Quarterly Financial Data (unaudited)

The following table contains selected quarterly financial information for 2018 and 2017. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair statement of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.

 

 

 

Three Months Ended

 

 

 

March 31, 2018

 

 

June 30, 2018

 

 

September 30, 2018

 

 

December 31, 2018

 

Revenue

 

$

370

 

 

$

375

 

 

$

412

 

 

 

893

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

11,116

 

 

 

11,082

 

 

 

12,856

 

 

 

15,128

 

General and administrative

 

 

4,075

 

 

 

3,841

 

 

 

3,876

 

 

 

4,372

 

Total operating expenses

 

 

15,191

 

 

 

14,923

 

 

 

16,732

 

 

 

19,500

 

Loss from operations

 

 

(14,821

)

 

 

(14,548

)

 

 

(16,320

)

 

 

(18,607

)

Other income, net

 

 

358

 

 

 

501

 

 

 

583

 

 

 

575

 

Net loss applicable to common stockholders

 

$

(14,463

)

 

$

(14,047

)

 

$

(15,737

)

 

 

(18,032

)

Net loss per share applicable to common stockholders - basic and diluted

 

$

(0.48

)

 

$

(0.43

)

 

$

(0.47

)

 

 

(0.54

)

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

30,335,164

 

 

 

32,892,712

 

 

 

33,653,479

 

 

 

33,694,756

 

 

 

 

Three Months Ended

 

 

 

March 31, 2017

 

 

June 30, 2017

 

 

September 30, 2017

 

 

December 31, 2017

 

Revenue

 

$

1,101

 

 

$

 

 

$

 

 

$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

9,628

 

 

 

10,041

 

 

 

10,447

 

 

 

11,780

 

General and administrative

 

 

3,086

 

 

 

3,472

 

 

 

3,593

 

 

 

3,740

 

Total operating expenses

 

 

12,714

 

 

 

13,513

 

 

 

14,040

 

 

 

15,520

 

Loss from operations

 

 

(11,613

)

 

 

(13,513

)

 

 

(14,040

)

 

 

(15,520

)

Other income, net

 

 

98

 

 

 

145

 

 

 

215

 

 

 

218

 

Net loss applicable to common stockholders

 

$

(11,515

)

 

$

(13,368

)

 

$

(13,825

)

 

$

(15,302

)

Net loss per share applicable to common stockholders - basic and diluted

 

$

(0.49

)

 

$

(0.52

)

 

$

(0.53

)

 

$

(0.58

)

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

23,393,448

 

 

 

25,584,147

 

 

 

26,259,216

 

 

 

26,316,550